Literature DB >> 23157863

[Analysis and prediction of breast cancer incidence trend in China].

Ni Li1, Rong-shou Zheng, Si-wei Zhang, Xiao-nong Zou, Hong-mei Zeng, Zhen Dai, Wan-qing Chen.   

Abstract

OBJECTIVE: Based on the registered female breast cancer data from 1998 to 2007, to analyze the incidence of female breast cancer during the period and then to predict its trend from 2008 to 2015.
METHODS: The incidence data of breast cancer from 1998 to 2007 were sorted from National Cancer Registry Database, including 74 936 cases from urban areas and 8230 cases from rural areas, separately covering 164 830 893 and 55 395 229 person years. The crude incidence rates in urban and rural areas were calculated, and the age-standardized rate (ASR) was adjusted by World Segi's population composition. JoinPoint software was applied to analyze the 10 years' incidence trend and calculated the annual percentage of changing (APC), while Age-Period-Cohort Bayesian Model was used to fit the data and predict the incidence of breast cancer between 2008 and 2015.
RESULTS: From 1998 to 2007, the incidence of breast cancer in the urban cancer registration areas was 45.46/100 000 (74 936/164 830 893), whose ASR was 31.28/100 000. While in rural registration areas, the incidence and ASR was 14.86/100 000 (8230/55 395 229) and 12.13/100 000. The breast cancer incidence in urban and rural areas separately rose from 36.17/100 000 (3920/10 838 355) and 10.39/100 000 (436/4 197 806) in 1998 to 51.24/100 000 (11 302/22 057 787) and 19.61/100 000 (1475/7 522 690) in 2007. During the 10 years, the breast cancer incidence increased both in urban and rural areas, but the increase rate in rural incidence (6.3%) was more significant than it in urban areas (3.9%). Age-Period-Cohort Bayesian Model predicted that the breast cancer incidence would increase to 53.87/100 000 (185 585 new cases) in urban areas and 40.14/100 000 (132 432 new cases) in rural areas, respectively.
CONCLUSION: The breast cancer incidence has been increasing annually both in urban and rural areas in China; and an annually increase number of new cases have been predicted.

Entities:  

Mesh:

Year:  2012        PMID: 23157863

Source DB:  PubMed          Journal:  Zhonghua Yu Fang Yi Xue Za Zhi        ISSN: 0253-9624


  12 in total

Review 1.  Current situation and challenge of registry in China.

Authors:  Yang Zhang; Yuji Feng; Zhi Qu; Yali Qi; Siyan Zhan
Journal:  Front Med       Date:  2014-09-03       Impact factor: 4.592

2.  Astrocyte elevated gene-1 promotes the proliferation and invasion of breast cancer cells by activating the Wnt/β-catenin signaling pathway.

Authors:  Mengxi Li; Yuna Dai; Li Wang; Lei Li
Journal:  Oncol Lett       Date:  2017-02-08       Impact factor: 2.967

3.  Female breast cancer statistics of 2010 in China: estimates based on data from 145 population-based cancer registries.

Authors:  Hongmei Zeng; Rongshou Zheng; Siwei Zhang; Xiaonong Zou; Wanqing Chen
Journal:  J Thorac Dis       Date:  2014-05       Impact factor: 2.895

4.  Serum and hair zinc levels in breast cancer: a meta-analysis.

Authors:  Xiujuan Wu; Jing Tang; Mingjun Xie
Journal:  Sci Rep       Date:  2015-07-16       Impact factor: 4.379

5.  Urban-rural disparity of breast cancer and socioeconomic risk factors in China.

Authors:  Xufeng Fei; Jiaping Wu; Zhe Kong; George Christakos
Journal:  PLoS One       Date:  2015-02-17       Impact factor: 3.240

6.  Incidence rate of female breast cancer in urban Shijiazhuang in 2012 and modifiable risk factors.

Authors:  Denggui Wen; Yutong He; Lizhen Wei; Nan Zhang; Shumei Li; Xiaoduo Wen; Yi Yang; Guiying Wang; Shijie Wang; Cuizhi Geng; Yunjiang Liu; Baoen Shan
Journal:  Thorac Cancer       Date:  2016-05-26       Impact factor: 3.500

Review 7.  Health Disparity and Cancer Health Disparity in China.

Authors:  Qi Wang; Jie Jiao
Journal:  Asia Pac J Oncol Nurs       Date:  2016 Oct-Dec

8.  Epidemic trend, screening, and early detection and treatment of cancer in Chinese population.

Authors:  Xiao-Nong Zou
Journal:  Cancer Biol Med       Date:  2017-02       Impact factor: 4.248

9.  Effect of cycloxygenase-2 silencing on the malignant biological behavior of MCF-7 breast cancer cells.

Authors:  Sheng Yang; Hui Han
Journal:  Oncol Lett       Date:  2014-07-30       Impact factor: 2.967

Review 10.  Clinical utility of letrozole in the treatment of breast cancer: a Chinese perspective.

Authors:  Dong-Xu He; Xin Ma
Journal:  Onco Targets Ther       Date:  2016-03-01       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.